Testosterone Undecanoate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB13946 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 13 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | homozygous familial hypercholesterolemia | KG + DL |
| 2 | androgen insensitivity syndrome | KG + DL |
| 3 | Leydig cell hypoplasia due to LH resistance | KG + DL |
| 4 | 46,XY disorder of sex development due to impaired androgen production | KG + DL |
| 5 | symptomatic form of fragile X syndrome in female carrier | KG + DL |
| 6 | blepharophimosis-epicanthus inversus-ptosis | KG + DL |
| 7 | blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome | KG + DL |
| 8 | telecanthus | KG + DL |
| 9 | ovarian hyperstimulation syndrome | KG + DL |
| 10 | partial trisomy/tetrasomy of the short arm of chromosome 5 | KG + DL |
| 11 | partial trisomy/tetrasomy of the short arm of chromosome 12 | KG + DL |
| 12 | partial trisomy/tetrasomy of the short arm of chromosome 18 | KG + DL |
| 13 | stapes ankylosis with broad thumbs and toes | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.